The purpose of this study is to compare the effect of enhanced probiotic (EP, Live Rx) versus placebo (PL) on the incidence of Clostridium difficile associated diarrhea (CDAD) or antibiotic associated diarrhea (AAD) in hospitalized patients initiated on antibiotics.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
QUADRUPLE
Enhanced Probiotic, one packet bid until 7 days after discontinuation of antibiotic
Incidence of Clostridium difficle associated diarrhea in patients randomized to Go Live Rx compared with those randomized to placebo
Time frame: 60 days after hospitalization
Incidence of Antibiotic associated diarrhea in patients randomized to Go Live Rx compared with those randomized to placebo
Time frame: 60 Days after hospitalization
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.